期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 14, 期 12, 页码 1173-1176出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1469-0691.2008.02100.x
关键词
Diagnostics; Europe; multicentre; nucleic amplification technique; quality control; respiratory syncytial virus; sensitivity
资金
- Federal Office for Public Health, Switzerland
- F. Hofmann-La Roche Ltd
- Sanofi Pasteur and Sanofi Pasteur MSD
The performance of nucleic acid amplification techniques for detecting respiratory syncytial virus (RSV) was evaluated in 25 laboratories across Europe by an external quality assessment study. In addition, factors related to the diagnostic performance of laboratories were explored. The results of this quality control study show that the performance of laboratories for RSV diagnosis in Europe is good, with an overall correct score of 88%. The type of assay (nested or real-time PCR vs. commercial tests) was identified as a significant factor (OR 8.39; 95% CI 1.91-36.78) in predicting a correct result.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据